Subscribe To

Price Alert Latest News Economic Calendar News

RNAZ / TransCode Therapeutics Inc. (RNAZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

TransCode Therapeutics Inc. (RNAZ) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. Read More

Demo Live Account See Partner Details

Content Topics

Transcode

Therapeutics

Inc

RNAZ

Find

Bottom

Soon

Here

rnaz

Here s

Should

Stock

Posted: Jul 10 2023, 11:00

Author Name: Zacks Investment Research

RNAZ News

By InvestorPlace
October 27, 2023

Why Is TransCode Therapeutics (RNAZ) Stock Down 25% Today?

TransCode Therapeutics (NASDAQ: RNAZ ) stock is taking a beating on Friday after the oncology company announced plans for a public share offering. Tr

By InvestorPlace
September 26, 2023

Why Is TransCode Therapeutics (RNAZ) Stock Down 69% Today?

TransCode Therapeutics (NASDAQ: RNAZ ) stock is falling hard on Tuesday after the medical company announced a public share offering. According to a p

By Proactive Investors
September 26, 2023

Transcode Therapeutic stock whipsaws lower after cut price placing

TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug discovery firm rocketed Monda

By Proactive Investors
September 25, 2023

TransCode Therapeutics stock skyrockets on positive brain cancer trial results

TransCode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study of its lead drug candidate TTX-MC138 in mice mod

By Zacks Investment Research
July 10, 2023

TransCode Therapeutics Inc. (RNAZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

TransCode Therapeutics Inc. (RNAZ) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In a

By Pulse2
February 20, 2023

RNAZ Stock: 4.96% This Week Explanation

The stock price of TransCode Therapeutics, Inc. (Nasdaq: RNAZ) increased by 4.96% this past week. This is why.

By InvestorPlace
February 1, 2023

Why Is TransCode Therapeutics (RNAZ) Stock Up 45% Today?

TransCode Therapeutics (NASDAQ: RNAZ ) stock is rocketing higher on Wednesday following positive study results. The big news here has to do with TTX-R

By InvestorPlace
December 7, 2022

Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today?

TransCode Therapeutics (NASDAQ: RNAZ ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering. According to t

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.